These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11436957)

  • 21. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies.
    Aman MG; Buican B; Arnold LE
    J Child Adolesc Psychopharmacol; 2003; 13(1):29-40. PubMed ID: 12804124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of MPH-OROS on the organizational, time management, and planning behaviors of children with ADHD.
    Abikoff H; Nissley-Tsiopinis J; Gallagher R; Zambenedetti M; Seyffert M; Boorady R; McCarthy J
    J Am Acad Child Adolesc Psychiatry; 2009 Feb; 48(2):166-75. PubMed ID: 19127171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.
    Spencer TJ; Adler LA; McGough JJ; Muniz R; Jiang H; Pestreich L;
    Biol Psychiatry; 2007 Jun; 61(12):1380-7. PubMed ID: 17137560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Abikoff HB; Vitiello B; Riddle MA; Cunningham C; Greenhill LL; Swanson JM; Chuang SZ; Davies M; Kastelic E; Wigal SB; Evans L; Ghuman JK; Kollins SH; McCracken JT; McGough JJ; Murray DW; Posner K; Skrobala AM; Wigal T
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):581-92. PubMed ID: 17979579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis.
    Faraone SV; Biederman J
    J Atten Disord; 2002 Sep; 6(2):69-75. PubMed ID: 12142863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH.
    Kordon A; Stollhoff K; Niederkirchner K; Mattejat F; Rettig K; Schäuble B
    Postgrad Med; 2011 Sep; 123(5):27-38. PubMed ID: 21904084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.
    Stowe CD; Gardner SF; Gist CC; Schulz EG; Wells TG
    Ann Pharmacother; 2002; 36(7-8):1142-9. PubMed ID: 12086544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
    Bukstein OG; Kolko DJ
    J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term cardiovascular effects of methylphenidate and adderall.
    Findling RL; Short EJ; Manos MJ
    J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):525-9. PubMed ID: 11349696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial.
    Martins S; Tramontina S; Polanczyk G; Eizirik M; Swanson JM; Rohde LA
    J Child Adolesc Psychopharmacol; 2004; 14(2):195-206. PubMed ID: 15319017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylphenidate dosing: twice daily versus three times daily.
    Stein MA; Blondis TA; Schnitzler ER; O'Brien T; Fishkin J; Blackwell B; Szumowski E; Roizen NJ
    Pediatrics; 1996 Oct; 98(4 Pt 1):748-56. PubMed ID: 8885956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects.
    Ahmann PA; Theye FW; Berg R; Linquist AJ; Van Erem AJ; Campbell LR
    Pediatrics; 2001 Jan; 107(1):E10. PubMed ID: 11134474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
    Niederkirchner K; Slawik L; Wermelskirchen D; Rettig K; Schäuble B
    Expert Rev Neurother; 2011 Apr; 11(4):499-508. PubMed ID: 21469923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition.
    Hawk LW; Fosco WD; Colder CR; Waxmonsky JG; Pelham WE; Rosch KS
    J Child Psychol Psychiatry; 2018 Dec; 59(12):1271-1281. PubMed ID: 29733106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analog classroom assessment of Adderall in children with ADHD.
    Swanson JM; Wigal S; Greenhill LL; Browne R; Waslik B; Lerner M; Williams L; Flynn D; Agler D; Crowley K; Fineberg E; Baren M; Cantwell DP
    J Am Acad Child Adolesc Psychiatry; 1998 May; 37(5):519-26. PubMed ID: 9585654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.